Loading...

FITC anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_FITC
C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
  • RA3-6B2_FITC
    C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
Compare all formats See FITC spectral data
Cat # Size Price Save
103205 50 µg ¥6,600
103206 500 µg ¥19,650
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lunardi A, et al. 2015. Cancer Discovery. 5:550. PubMed
  2. Zaman R, et al. 2021. Immunity. :. PubMed
  3. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  4. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  5. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  6. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  7. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  8. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  9. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  10. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  11. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  12. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  13. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  14. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  15. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  16. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  17. Wang Z, et al. 2023. Mediators Inflamm. 2023:9810733. PubMed
  18. Israelow B, et al. 2020. bioRxiv. . PubMed
  19. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  20. Hata E, et al. 2016. Int Immunol. 28: 283 - 292. PubMed
  21. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  22. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  23. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  24. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  25. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  26. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  27. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  28. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  29. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  30. Dong L, et al. 2021. Cancer Cell. . PubMed
  31. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  32. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  33. Kelly L, et al. 2011. J Immunol. 187:3026. PubMed
  34. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  35. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  36. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  37. Zhu X, et al. 2017. Arch Oral Biol. 10.1016/j.archoralbio.2017.03.010. PubMed
  38. Jones M, et al. 2016. PLoS One. 11: 0157271. PubMed
  39. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  40. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  41. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  42. Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  43. Carbonneau C, et al. 2012. Blood. 119:717. PubMed
  44. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  45. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  46. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  47. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  48. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  49. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  50. Zanotti KJ, et al. 2019. J Immunol. 202:1573. PubMed
  51. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  52. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  53. Huang L, et al. 2017. PLoS Biol.. 10.1371/journal.pbio.2001750. PubMed
  54. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  55. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  56. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  57. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  58. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  59. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  60. Nakata T, et al. 2020. Proc Natl Acad Sci U S A. 117:28930. PubMed
  61. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  62. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  63. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  64. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  65. Köchl R, et al. 2020. Elife. 9:00. PubMed
  66. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  67. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  68. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  69. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  70. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  71. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  72. Nabar NR, et al. 2022. Autophagy. 18:204. PubMed
  73. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  74. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  75. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  76. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  77. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  78. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  79. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  80. Hutter K, et al. 2020. FEBS J. . PubMed
  81. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  82. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  83. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  84. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  85. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  86. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  87. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  88. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  89. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  90. Roy K, et al. 2019. Immunity. 50:616. PubMed
  91. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  92. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  93. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  94. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  95. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  96. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  97. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  98. Li H, et al. 2020. Nature. 584:274. PubMed
  99. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  100. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  101. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  102. Morrison V, et al. 2015. J Immunol. 195: 105 - 115. PubMed
  103. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  104. Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
  105. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  106. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  107. Liu R, et al. 2018. Front Immunol. 9:592. PubMed
  108. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  109. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  110. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  111. Liu J, et al. 2021. Immun Inflamm Dis. 9:299. PubMed
  112. Liu R, et al. 2021. Mol Cell Biol. 41:e0025121. PubMed
  113. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  114. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  115. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  116. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  117. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  118. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  119. Weng TY, et al. 2018. Sci Rep. 8:8216. PubMed
  120. Zhang C, et al. 2021. J Virol. 95:e0079021. PubMed
  121. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  122. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  123. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  124. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  125. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  126. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  127. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  128. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  129. Nguyen HTT, et al. 2021. PLoS Pathog. 17:e1010026. PubMed
  130. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  131. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  132. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  133. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  134. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  135. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  136. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  137. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  138. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  139. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  140. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  141. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  142. Ota T, et al. 2011. J Exp Med. 208:617. PubMed
  143. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  144. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  145. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  146. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  147. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  148. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  149. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  150. Pan J, et al. 2022. Front Immunol. 13:812924. PubMed
  151. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  152. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  153. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  154. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  155. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
RRID
AB_312990 (BioLegend Cat. No. 103205)
AB_312990 (BioLegend Cat. No. 103206)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

Other Formats

View All CD45R/B220 Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F,FC,3D IHC
APC anti-mouse/human CD45R/B220 RA3-6B2 FC
Biotin anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
FITC anti-mouse/human CD45R/B220 RA3-6B2 FC
PE anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Cyanine5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
PE/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 488 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Cyanine5.5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 421™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
Brilliant Violet 570™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 650™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 605™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 785™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 510™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,SB
Purified anti-mouse/human CD45R/B220 (Maxpar® Ready) RA3-6B2 FC,CyTOF®
Brilliant Violet 711™ anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Dazzle™ 594 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 750 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 750™ anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-A0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Spark Blue™ 550 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark NIR™ 685 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-B0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Ultra-LEAF™ Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
TotalSeq™-C0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
PE/Fire™ 640 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Fire™ 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Violet™ 538 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 581 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 570 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F
PE/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Red™ 718 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark UV™ 387 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark PLUS UV395™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Go To Top Version: 2    Revision Date: 04/25/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account